Read 6 min
This story appears in the
Mexico. Subscribe to “
The legislation of the cannabis It is an issue that has been addressed for decades and is undoubtedly one of the great controversies that some countries have submitted for its status, only in America, Canada and the United States has this facility become legal for theirs Leisure use in the famous “coffee shops” and in the medical field.
The marijuana – as it is colloquially called – it will not only have an impact on the pharmaceutical or chemical industry, but will also offer great opportunities for comprehensive waste disposal. And as an example I would like to refer to the different uses of Cannabis sativa, identified in a recent study on the technological intelligence of this culture; For example, worldwide we find various industries with more than 3,500 families of registered patents representing more than 10,000 publications, of which only 33% of the total families have been granted – China is one of the main generators of solutions in the area. This gives us an idea of the investment being made worldwide in this regard.
Only in our country will the marijuana market reach $ 2 billionFor cannabis-based products, the evolution of the number of requests for innovation in this area is reflected in the fact that cannabis use and studies are increasing.
In fact, we see Mexico in 12th place among the countries with the most patents pending, only below China, the United States and Canada; This opens up great opportunities for companies intending to enter this market, but at the same time enables us to understand where the threats and opportunities of international competitors lie at the technological level and how their technology is used in products.
With this in mind, the Federal Commission for Protection from Health Risks (Cofepris) issued around 60 permits at the end of last year for the production of raw materials, food, beverages, food supplements, cosmetics and pharmaceuticals based on cannabis.
The evolution of the number of requests for innovation in this area is reflected in the fact that cannabis use and studies are increasing so that we can understand the level of maturity of the past decade. In 1996 alone there were 14 cannabis families, 18 of which were registered and only 13 patents were designed. However, the families increased and only in 2016 839 classifications were discovered and 1034 applications, of which only 317 were accepted.
Despite the fact that technology and needs have progressed over the years, only 597 families, 144 registrations and 278 patents were designed in 2018, allowing us to see the effectiveness of investments in this matter.
It should be recalled that Mexican Senators from the Health and Justice Commission broadly approved the regulation of recreational marijuana use on March 4. With this in mind, it is important to take this into account In addition to the many details that are discussed about its regulation, there is another reality on the research and development side of applications in rapidly growing areas such as medicine.
An important issue regarding the plant is that, according to the National Association of the Cannabis Industry (Anicann), legalizing the plant brings other benefits that are not only economical, but also ecological, ecological, and medical. Hemp has more than 1,500 uses. For example, it is made with the seeds from protein powder, milk, beer, and even fuel; while the leaves form butter and infusions, among other things, which opens up a number of business opportunities. In addition, according to Anicann, there are approximately 40 million Mexicans in Mexico who suffer from critical pain that can be treated with hemp products.
Mexico is also important not only for the presence of the country’s most important international laboratories, but also for its work in local production and for quality in research and development, as part of the study on the use of cannabis sativa The technological Leading the companies that give the most presentations worldwide highlights pharmaceutical, food and chemical companies. The 35 companies that lead the technology in this area include BASF, Bayer, Bristol Myers Squibb, Pfizer and Sanofi.
With this in mind, the good news is that, despite the sluggish regulatory performance, investment in cannabis medical research over the past two decades has increased by 1000% worldwide, thereby opening up an important space in Mexico in an assertive manner address the issue and identify opportunities for lines of research or the potential acquisition and licensing of technology.
I dont know